SIO2021 Program

Moderators: Sean Tutton, Medical College of Wisconsin, USA; Dimitrios Filippiadis, University General Hospital Attikon, Greece

Francois Cornelis, Sorbonne University, France: Overview of IO Non-Opiate Pain Palliation Pt. Selection/Evaluation (11:00am EST - 11:12am EST)

Dimitrios Filippiadis, University General Hospital Attikon, Greece: Treatment Options for Neurogenic & Bone Cancer Pain (11:12am EST - 11:24 am EST)

Sarah White, Medical College of Wisconsin, USA: Fluid/Gas/Air Management (11:24am EST - 11:36am EST)

David Prologo, Emory University, USA: Outcomes/Best Papers (11:36am EST - 11:48am EST)

Roberto Luigi Cazzato, University Hospital of Strasbourg, France: Advanced Pain Palliation Procedure (11:48am EST - 12:00pm EST)

Q&A: 12:00pm EST -
12:15pm EST

Mini-Masterclass: Liver Directed Therapies

Moderators: Karen Brown, University of Utah, USA; Robert Lewandowski, Northwestern University, USA

Karen Brown, University of Utah, USA: Patient Selection (11:00am EST - 11:12am EST)

Beau Toskich, Mayo Clinic, USA: Avoiding and Managing Complications in Liver Directed Therapy (11:12am EST - 11:24am EST)

Robert Lewandowski, Northwestern University, USA: "How I Do It" - Catheter Directed Liver Therapy (11:24 am EST - 11:36am EST)

Steven Raman, UCLA, USA: "How I Do It" - Ablation (11:36am EST - 11:48am EST) 

Lambros Tselikas, Gustave Roussy, France: IO Outcomes/CE/Best Papers to Know (11:48am EST - 12:00pm EST) 

Edward Kim, Mount Sinai Health Systems, USA: Advanced Techniques: Personalized Dosimetry/Same Day Y90 (12:00pm EST - 12:12pm EST)

Q&A: 12:12pm EST - 12:15pm EST

Mini-Masterclass: GU

Moderators: Raj Shah, Stanford University, USA; Jeremy Durack, Memorial Sloan Kettering Cancer Center, USA

Brian Welch, Mayo Clinic, USA: Patient Selection (1:00pm EST - 1:12pm EST)

Samdeep Mouli, Northwestern University, USA: Complications of RCC Ablation (1:12pm EST - 1:24pm EST)

Adam Talenfeld, Weill Cornell Medicine, USA: Outcomes/Best Papers/CER (1:24pm EST - 1:36pm EST)

Jason Hoffman, Winthrop University Hospital, USA: Advanced RCC (1:36pm EST - 1:48pm EST)

Ronald Arellano, Massachusetts General Hospital, USA: How I Do It (1:48pm EST - 2:00pm EST)

Q&A: 2:00pm EST - 2:15pm EST

Mini-Masterclass: Lung

Moderators: Damian Dupuy Brown University, Brigham Radiology, USA; Rob Suh, Ronald Reagan UCLA Medical Center, USA

Alda Tam, MD Anderson Cancer Center, USA: Patient and Tumor Selection (1:00pm EST - 1:12pm EST)

Stephen Hunt, Hospital of the University of Pennsylvania, USA: How I Do It (1:12pm EST - 1:24pm EST)

David Wang, Stanford University School of Medicine, USA: Outcomes, Comparative Effectiveness and Best Papers (1:24pm EST - 1:36pm EST)

Florian Fintelmann, Massachusetts General Hospital, USA: Complications Management and Follow-Up (1:36pm EST - 1:48pm EST)

Fereidoun Abtin, UCLA, USA: Advanced Techniques (1:48 pm EST - 2:00pm EST)

Q&A: 2:00pm EST - 2:15pm EST

Mini-Masterclass: Practice Building

Moderators: Scott Genshaft, UCLA, USA; Aneesa Majid, No Limits Radiology, USA

Mary Costantino, Advanced Vascular Centers, USA: Billing (3:00pm EST - 3:12pm EST)

Scott Genshaft, UCLA, USA: Telemedicine in IR (3:12pm EST - 3:24pm EST)

Jennifer Razor, Cirrina Law, USA: Medicare Process (3:24pm EST - 3:36pm EST)

Anthony Brown, Radiology Imaging Associates Endovascular, USA: OBL and IO (3:36pm EST - 3:48pm EST)

Janice Newsome, Winship Cancer Institute, Emory University, USA: Building IO in Academic Practice (3:48pm EST - 4:00pm EST)

Q&A: 4:00pm EST - 4:15pm EST

Mini-Masterclass: Arterial and Venous Interventions

Moderators: Scott Trerotola, Perelman School of Medicine at the University of Pennsylvania, USA; John Moriarty, UCLA, USA

Scott Trerotola, Perelman School of Medicine at the University of Pennsylvania, USA: Right Line, Right Patient, Right Time (3:00pm EST - 3:12pm EST)

Rusty Hofmann, Stanford University, USA: Acute Lower Extremity DVT (3:12pm EST - 3:24pm EST)

Stephen Chen, MD Anderson Cancer Center, USA: Vascular Emergency - Head & Neck (3:24pm EST - 3:36pm EST)

John Moriarty, UCLA, USA: PE in the Cancer Patient (3:36pm EST - 3:48pm EST)

Bill Majdalany, Emory University, USA: Lymphatic Intervention and Post-Op Embolization (3:48pm EST - 4:00pm EST)

Q&A: 4:00pm EST - 4:15pm EST

Abstract Presentations

• Radiologic-Pathologic Analysis of Novel Ethanol Gel Formulation for Percutaneous Ablation in a Rat Liver Model, Erika Chelales
• Image Guidance and Assessment of Histotripsy Ablations Using Cone-Beam CT, Sarvesh Periyasamy
• Prevalence of Goals of Care Discussions and Palliative Care Consultations Prior to Interventional Oncology Procedures, Summer Beeson
• Retrospective Cohort Analysis of an Enhanced Recovery After Procedure (ERAP) Pathway is Associated with Decreased Peri-procedural Opioid Consumption for CT-Guided Liver Microwave Ablation Procedures, Rafael Vasquez
• Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns and survival, Yi Yang
• MWA ablation of T1a and T1b renal cell carcinomas: Prognostic factors affecting the progression survival rates, Evgenia Efthymiou
• Safety, tolerability and efficacy of transarterial chemoembolization using anthracyclines-loaded drug eluting microspheres for the treatment of patients with hepatocellular carcinoma: Pooled Analyses, Filipe Veloso Gomes
• Transarterial chemoembolization for neuroendocrine tumor liver metastases : A 15-year monocentric experience, Caroline Touloupas
• Quantitative ultrasound to guide intraprocedural decision-making: preclinical assessment in a clinically relevant rat liver cancer model, Ryosuke Taiji
• Quantitative Analysis of Microwave Lung Ablation Zones, Arvind Dev
• Q&A

Interventional Oncology and the NCCN Guidelines

Moderator: Sarah White, Medical College of Wisconsin, USA

William Stavropoulos, Perelman School of Medicine at the University of Pennsylvania, USA: NCCN Guidelines Demystified (10:45am EST - 10:54am EST)

Beau Toskich, Mayo Clinic, USA: Where Does IO Stand in the NCCN Guidelines: HCC (10:54am EST - 11:03am EST)

Daniel Brown, Vanderbilt University, USA: Where Does IO Stand in the NCCN Guidelines: ICC (11:03am EST - 11:12am EST)

Ahmed Kamel Abdel Aal, UTHealth, USA: Where Does IO Stand in the NCCN Guidelines: mCRC (11:12am EST - 11:21am EST)

Nicholas Fidelman, UCSF, USA: Where Does IO Stand in the NCCN Guidelines: mNET and Other Tumor Types (11:21am EST - 11:30am EST)

Alda Tam, MD Anderson Cancer Center, USA: Where Does IO Stand in the NCCN Guidelines: Lung and Metastases to the Lung (11:30am EST - 11:39am EST)

Nadine Abi-Jaoudeh, UCI Health, USA: Where Does IO Stand in the NCCN Guidelines: RCC (11:39am EST - 11:48am EST)

William Rilling, Medical College of Wisconsin/Froedtert Hospital, USA: Where Do We Need to Go?: Clinical Trial Design to get IO into NCCN (11:48am EST - 11:57am EST)

Riad Salem, Northwestern University, USA: Where Do We Need to Go?: Meaningful Outcome Measures for Interventional Oncology (11:57am EST - 12:06pm EST)

Panel Discussion (12:06pm EST - 12:15pm EST)

Oligometastatic Disease

Moderators: Dan Sze, Stanford University, USA; Lambros Tselikas, Gustave Roussy, France 

Damian Dupuy, Brown University, Brigham Radiology, USA: Intro to Oligometastatic Disease & Rationale: (12:15pm EST - 12:27pm EST)

Billy Loo, Stanford University, USA: Radiation & Oligometastatic Lung Cancer (12:27pm EST - 12:39pm EST)

Janani Reisenauer, Mayo Clinic, USA: Surgical Perspective in Oligometastatic Colorectal Cancer/Sarcoma (12:39pm EST - 12:51pm EST)

Dan Sze, Stanford University, USA: IR/IO Role in Oligometastatic (12:51pm EST - 1:03pm EST)

Q&A: 1:03pm EST - 1:30pm EST

AI in Oncology

Moderators: William Rilling, Medical College of Wisconsin/Froedtert Hospital, USA; Matt Callstrom, Mayo Clinic, USA

Michael Muelly, NewCo and Stanford University, USA: The Artificial Intelligence Revolution (12:15pm EST - 12:27pm EST)

Bradford Wood, National Institutes of Health, USA: Wearables (12:27pm EST - 12:39pm EST)

Aaron Abajian, Cronote Reminder, USA: Treatment Planning & Verification: Learning from the Masters (12:39pm EST - 12:51pm EST)

Punit Prakash, Kansas State University, USA: Simulation and Guidance (12:51pm EST - 1:03pm EST)

Jeff Schlosser, Stanford University, USA: Robotics (1:03 pm EST - 1:15pm EST)

Q&A: 1:03pm EST - 1:30pm EST

Immunotherapy in Advanced Metastatic Disease

Moderators: Philippe Pereira, SLK Kliniken GmBH, Germany; Joseph Erinjeri, Memorial Sloan Kettering Cancer Center, USA

Millie Das, Stanford University/VA Palo Alto Health Care System, USA: Immunotherapy Overview (1:45pm EST - 1:57pm EST)

Mikhail Silk, Memorial Sloan Kettering Cancer Center, USA:  Intratumoral Injection (1:57pm EST - 2:09pm EST)

Rahul Sheth, MD Anderson Cancer Center, USA: Ablation & Immunotherapy (2:09pm EST - 2:21pm EST)

Antonia Digklia, CHUV, Department of Oncology, University Hospital, Lausanne, Switzerland: Response Assessment (2:21pm EST - 2:33pm EST)

Kevin Kim, University of Maryland School of Medicine, USA: Adoptive T-cell Therapy (2:33pm EST - 2:45pm EST)

Abstract Presentation: In-depth analysis of immune responses following cryoablation in melanoma, Chakradhar Yakkala (2:45pm EST - 2:52pm EST)

Abstract Presentation: Characterization of local and abscopal immune responses generated by histotripsy focused ultrasound tumor ablation, Reliza McGinnis (2:52pm EST - 2:59pm EST)

Q&A (2:59pm EST - 3:15pm EST)

Pancreaticobiliary

Moderators: Gianpaolo Carrafiello, University of Milano, Italy; Martijn Meijerink, Amsterdam UMC, Nederlands

Monica Dua, Stanford University, USA: Surgical Considerations of Hepatobiliary and Pancreatic Malignancies (1:45pm EST - 1:57pm EST)

Gianpaolo Carrafiello, University of Milano, Italy: Role of IR in Presurgical Management of Cholangiocarcinoma (1:57pm EST - 2:09pm EST)

Martijn Meijernik, Amsterdam UMC - Cancer Center Amsterdam, Nederlands: Locoregional Therapy for Unresectable Disease (2:09pm EST - 2:21pm EST)

Govindarajan Narayanan, Miami Cardiac and Vascular Institute, USA: IRE for Pancreatic Cancer (2:21pm EST - 2:33pm EST)

Ann Raldow, UCLA, USA: SBRT for Pancreatic Adenocarcinoma (2:33pm EST - 2:45pm EST)

Abstract Presentation: Real-world outcomes of patients with intrahepatic cholangiocarcinoma treated with trans-arterial radioembolization: results from CIRT, a large European prospective multi-centre observational study, Thomas Helmberger (2:45pm EST - 2:52pm EST)

Abstract Presentation: Immunomodulation by ablation in locally advanced pancreatic cancer: Percutaneous IRE vs. MR-guided SABR, Bart Geboers (2:52pm EST - 2:59pm EST)

Q&A (2:59pm EST - 3:15pm EST)

HCC Tumor Board

Moderator: Laura Crocetti, University of Pisa, Italy

Claude Sirlin, UC San Diego, USA 

Robin Kate Kelley, UC San Francisco, USA 

Andy Bonham, Stanford, USA 

Laura Dawson, PMH, University of Toronto, Canada  

Laura Crocetti, University of Pisa, Italy  

Q&A (4:35pm EST - 5:00pm EST)

HCC Current Controversies

Moderators: Dave Liu, Vancouver Coastal Health, Canada; Laura Crocetti, University of Pisa, Italy

Claude Sirlin, UC San Diego, USA: Is Biospy Dead in the Era of LIRADS? (5:15pm EST - 5:27pm EST)

Robin Kate Kelley, UC San Francisco, USA: Changing Landscape of Systemic Therapy for HCC (5:27pm EST - 5:39pm EST)

Andy Bonham, Stanford, USA Transplantation Triage (5:39pm EST - 5:51pm EST)

Dave Liu, Vancouver Coastal Health, Canada: Transarterial Therapies for HCC: Have We Reached Consensus?/Personalized Dosimetry for Y90 (5:51pm EST - 6:03 pm EST)

Laura Dawson, PMH, University of Toronto, Canada: Is SABR Definitive Treatment for HCC? (6:03pm EST - 6:15pm EST)

Laura Crocetti, University of Pisa, Italy: Is Ablation Definitive Treatment for HCC? (6:15pm EST - 6:27pm EST)

Abstract Presentation: Delayed Treatment Response after Radiation Segmentectomy: Is 3 months follow up enough?, Shanmukha Srinivas (6:27pm EST - 6:34pm EST)

Q&A (6:34pm EST - 6:45pm EST)

Drug Delivery Barriers: Tumor Micro Environment

Moderators: David Madoff, Yale School of Medicine, USA; Sarah White, Medical College of Wisconsin, USA

Rahul Sheth, MD Anderson Cancer Center, USA: Hypoxia and Drug Perfusion (5:15pm EST - 5:27pm EST)

Terence Gade, University of Pennsylvania, USA: Barriers to Drug Delivery in Solid Tumors: What Every Interventional Oncologist Should Consider (5:27pm EST - 5:39pm EST)

Scott Thompson, Mayo Clinic, USA: Tumor Microenvironment and Immune Modulation (5:39pm EST - 5:51pm EST)

Q&A (5:51pm EST - 6:00pm EST)

Imaging Uses of Ethiodol

Moderator: Julius Chapiro, Yale University, USA

Julius Chapiro, Yale University, USA: Ethiodol as a Bio Marker (6:00pm EST - 6:12pm EST)

Nishita Kothary, Stanford University, USA: Cost Effectiveness and Advanced Imaging (6:12pm EST - 6:24pm EST)

Masanori Inoue, Keio University, Japan: Hepatic Lymphorrhea: Access and Treatment (6:24pm EST - 6:36pm EST)

Q&A (6:36pm EST - 6:45pm EST)

Industry Symposium - Clinical Case Series: Radiofrequency Ablation for Bone Metastases

Supported by Medtronic

Mary Jesse, University of Colorado

CIO Session Swap: Tips and Tricks to Optimizing IO Outcomes

Moderators: Ripal Gandhi, Miami Cardiac and Vascular Institute, USA; Constantino Peña, Baptist Health South Florida, USA

Thierry de Baere, Institute Gustave Roussy, France: Conventional Chemoembolization: My Top 5 Technical Pearls (11:00:00am EST - 11:05am EST)

Karen Brown, University of Utah, USA: Bland Embolization: My Top 5 Technical Pearls (11:05am EST - 11:10EST) 

Govindarajan Narayanan, Miami Cardiac and Vascular Institute, USA: Drug Eluting Bead Embolization: My Top 5 Technical Pearls (11:10am EST - 11:15am EST)

Panel Discussion (11:15am EST - 11:30am EST)

Siddharth Padia, UCLA, USA: Y90 Segmentectomy and Lobectomy: My Top 5 Technical Pearls (11:30am EST - 11:35am EST)

Alban Denys, University of Lausanne, Switzerland: Portal Vein Embolization: My Top 5 Technical Pearls (11:35am EST - 11:40am EST)

Constantinos Sofocleous, Memorial Sloan Kettering Cancer Center, USA: Thermal Ablation of Hepatic Dome Tumors: My Top 5 Technical Pearls (11:40am EST - 11:45am EST)

Panel Discussion (11:1\45am EST - 12:00pm EST)

Industry Symposium - AngioCT in Interventional Radiology: A Breakthrough for Clinical Outcome (11:00am - 11:45am)

Sponsored by Siemens Healthineers

Jafar Golzarian, University of Minnesota, USA

Games and Networking

mCRC Tumor Board

Moderators: Constantinos Sofocleous, Memorial Sloan Kettering Cancer Center, USA; Mike Soulen, University of Pennsylvania, USA

George Fisher, Stanford University, USA 

Yuman Fong, City of Hope, USA 

David Lu, UCLA, USA 

Siddharth Padia, UCLA, USA 

Irene Bargellini, Pisa University Hospital, Italy 

Martijn Meijerink, Amsterdam UMC, Nederlands

Q&A (1:15pm EST - 1:30pm EST)

Metastatic Colorectal Disease: Current Issues

Moderators: Constantinos Sofocleous, Memorial Sloan Kettering Cancer Center, USA; Mike Soulen, University of Pennsylvania, USA

George Fisher, Stanford University, USA: Understanding the Canonical System and Molecular Stratification of Colorectal Disease (1:45pm EST - 1:57pm EST)

Yuman Fong, City of Hope, USA: Small Complete Response Disease: What to Do? (1:57pm EST - 2:09pm EST)

David Lu, UCLA, USA: Ablation in the Era of Parenchymal-Sparing Laparoscopic Surgery: Game Over? (2:09pm EST - 2:21pm EST)

Siddharth Padia, UCLA, USA: Radioembolization Post Global FOXFIRE Studies: Where Are We? (2:21pm EST - 2:33pm EST)

Irene Bargellini, Pisa University Hospital, Italy: Embolization and HAI: Where Do They Stand? (2:33pm EST - 2:45pm EST)

Robbert Puijk, Amsterdam UMC - Cancer Center Amsterdam, Nederlands: Advanced Imaging to Define Ablation (2:45pm EST - 2:57pm EST)

Abstract Presentation: Prediction of future liver remnant hypertrophy after Portal Vein Embolization in patients with colorectal liver metastases – a proof-of-concept machine-learning based approach, Tom Kuhn (2:57pm EST - 3:04pm EST)

Q&A (3:04pm EST - 3:15pm EST)

Immuno-oncology and Interventional Oncology for HCC

Moderator: Kevin Kim, University of Maryland School of Medicine, USA

Bruno Sangro, The University of Navarra School of Medicine, Spain: Current state of Immunotherapy for HCC (1:45pm EST - 1:55pm EST)

Masatoshi Kudo, Kindai University Osaka, Japan: Combination Immunotherapy for HCC (1:55pm EST - 2:05pm EST)

Riccardo Lencioni, University of Miami Miller School of Medicine, USA: Immunotherapy and Its Current Place in Practice Guidelines (2:05pm EST - 2:15pm EST)

Tim Greten, NIH Center for Cancer Research, USA: Immunotherarpy combined with Interventional Oncology: What is the current state? (2:15pm EST - 2:25pm EST)

Q&A (2:25pm EST - 2:30pm EST)

Referral Patterns: Where Does Y90 Fit in Treatment of Cholangiocarcinoma?

Moderator: Robert Lewandowski, Northwestern University, USA

Tom Karasic, the Hospital of the University of Pennsylvania, USA: Medical Oncologist Perspective (2:30pm EST - 2:40pm EST)

Robert Roses, University of Pennsylvania, USA: Surgical Oncologist Perspective (2:40pm EST - 2:50pm EST)

Veronica Loy, Medical College of Wisconsin, USA: Hepatologist Perspective (2:50pm EST - 3:00pm EST)

Robert Lewandowski, Northwestern University, USA: Interventional Oncologist Perspective (3:00pm EST - 3:10pm EST )

Q&A (3:10pm EST - 3:15pm EST)

SIO Sponsored Research

Moderator: Martijn Meijerink, Amsterdam UMC, Nederlands

Julius Chapiro, Yale University, USA: Molecular Imaging of the Immuno-Metabolic Crosstalk to guide Combination Therapies of Liver Cancer (3:45pm EST - 4:00pm EST)

Rony Avritscher, MD Anderson Cancer Center, USA: Reducing Post embolization Immunosuppression with Lipiodol TACE (4:00pm EST - 4:15pm EST)

Dong-Hyun Kim, Northwestern University, USA: Development of Immune Check Point Inhibitor Loaded Lipiodol for Local Immunotherapy of HCC (4:15pm EST - 4:30pm EST)

Kelley Nunez, Ochsner Medical Center, USA: Tumor-Induced Tolerance in Driving Embolization Resistance and Waitlist / Transplant Outcomes (4:30pm EST - 4:45pm EST)

Q&A (4:45pm EST - 5:00pm EST)

Meet the Experts

Moderators: Afshin Gangi, University Hospital of Strasbourg, NHC, France; Alexis Kelekis, National and Kapodistrian University of Athens, Greece

Michael C. Soulen, University of Pennsylvania, USA & David Madoff, Yale School of Medicine, USA: HCC and Liver Metastatic Disease (3:45pm EST - 4:10pm EST)

Damian Dupuy, Brown University, USA & Ronald Arellano, Massachusetts General Hospital, USA: Lung and Renal (4:10pm EST - 4:35pm EST)

Sean Tutton, Medical College of Wisconsin, USA & Matt Callstroum, Mayo Clinic, USA: MSK and Spine (4:35pm EST - 5:00pm EST)

Industry Symposium - Integrating Y-90 into the mCRC Pathway: A Surgical Perspective

Sponsored by Sirtex

Rohan Jeyarajah, Methodist Richardson Medical Center Chair, Department of Surgery

Tom Kuhn, Yale School of Medicine, USA: LiPreX - the easy-to-use liver hypertrophy prediction tool

Seth Berkowitz, Beth Israel Deaconness Medical Center, Harvard Medical School, USA: Machine learning detection of reflux during transarterial embolization

Hongyu Wang, University of Texas Health Science Center (UT Health), USA: Artificial intelligence-based outcome perdition for TACE treatment

Charlie Hamm, Institute of Radiology Charté, Germany: Interpretable deep learning classification of prostate cancer on MRI

Lynne Martin, Stanford University, USA: Hepatocellular Carcinoma in Veterans: How AI can determine factors affecting the care and survival of our Veterans with HCC

Aaron Wang, Brown University, USA: Registration-Based Neural Network to Create 3D Biomechanical Deformable Image of Liver

Michelle Bardis, University of California Irvine, USA: Convolutional Neural Network Machine Learning Algorithm for Segmentation and Evaluation of Renal Tumors prior to Percutaneous Ablation

Ningcheng Li, Oregon Health & Science University, USA: Augmented reality registration for procedural imaging guidance (AR4IR)

New Drug Delivery Vehicles

Moderators: Sarah White, Medical College of Wisconsin, USA; Frederic Deschamps, Institute Gustave Roussy, France

Sarah White, Medical College of Wisconsin, USA: Nano Particles (11am EST - 11:12am EST)

Frederic Deschamps, Institute Gustave Roussy, France: New Developments in Liquid Embolics 11:12am EST - 11:24am EST)

Thomas Vogl, University Hospital Frankfurt, Germany: Emerging Radioembolization Platforms for the Treatment of Cancer of Liver (11:24am EST - 11:36am EST)

Jafar Golzarian, University of Minnesota, USA: Update on Bead Technology (11:36am EST - 11:48am EST)

Q&A (11:48am EST - 12:00pm EST)

Industry Symposium: Groundbreaking Studies in IO DOSISPHERE-01 and SOLSTICE 

(11:00 am - 11:45 am)

Sponsored by Boston Scientific Corporation

Matthew Callstrom, MD, PhD, Mayo Clinic, USA

Etienne Garin, MD

Lung Tumor Board

Moderators: Steve Solomon, Memorial Sloan Kettering Cancer Center, USA; Rob Suh, Ronald Reagan UCLA Medical Center, USA

Jane Yanagawa, UCLA, USA 

Albert Chang, UCLA, USA 

Millie Das, Stanford University/VA Palo Alto Health Care System, USA 

Rob Short, Dayton VA Medical Center, USA 

Roberto Casal, MD Anderson Cancer Center, USA 

Damian Dupuy, Brown University, USA 

Lung

Moderators: Steve Solomon, Memorial Sloan Kettering Cancer Center, USA; Rob Suh, Ronald Reagan UCLA Medical Center, USA

Jane Yanagawa, UCLA, USA: How Can Other Forms of Local Control Complement Surgical Resection? (1:45pm EST - 1:57pm EST)

Albert Chang, UCLA, USA: Brachyablation of Central Lung Tumors (1:57pm EST - 2:09pm EST)

Rob Short, Dayton VA Medical Center, USA: We Can Ablate, So What's Next? (2:09pm EST - 2:21pm EST)

Roberto Casal, MD Anderson Cancer Center, USA: Interventional Pulmonary - Can We Get to Ablation? (2:21pm EST - 2:33pm EST)

Damian Dupuy, Brown University, USA: Lung Ablation Imaging (2:33pm EST - 2:45pm EST)

Abstract Presentation: Assessment of transbronchial microwave ablation zone using mobile C-arm CBCT: in vivo porcine model results, Sarvesh Periyasamy (2:45pm EST - 2:52pm EST)

Aaron Lisberg, UCLA, USA: Metastatic NSCLC: Systemic Therapy, Local Control, and Oligometastic Disease (2:52pm EST - 3:04pm EST)

Q&A (3:04pm EST - 3:15pm EST)

MSK

Moderator: Afshin Gangi, University Hospital of Strasbourg, NHC, France

Matt Callstrom, Mayo Clinic, USA: MSK Ablation Basics – Pain Palliation (1:45pm EST - 1:57pm EST)

Kristofer Schramm, University of Colorado, USA: MSK Ablation Basics - Local Disease Control (1:57pm EST - 2:09pm EST)

Sean Tutton, Medical College of Wisconsin, USA: Peripheral Augmentation – From Cement to Metal (2:09pm EST - 2:21pm EST)

Afshin Gangi, University Hospital of Strasbourg, NHC, France: Metastatic Spine – Principles and Tools for Treatment (2:21pm EST - 2:33pm EST)

Pejman Ghanouni, Stanford University, USA: HiFU for Bone Metastases (2:33pm EST - 2:45pm EST)

MK Jesse: University of Colorado, USA: Avoid and Manage Pitfalls and Problems (2:45pm EST - 2:57pm EST)

Abstract Presentation: Complications of Percutaneous Radiofrequency Ablation of Spinal Osseous Metastases: An 8-Year Single-Center Experience, Anderanik Tomasian (2:57pm EST - 3:04pm EST)

Q&A (3:04pm EST - 3:15pm EST)

GU

Moderators: David Breen, University Hospitals Southampton, UK; Naomi Balzer Haas, Hospital of the University of Pennsylvania, USA

Tim McClure, Cornell, USA: T1B Lesions: IR Approaches (3:45pm EST - 3:57pm EST)

John Leppert, Stanford University, USA: T1B Lesions: Surgeon Approaches (3:57pm EST - 4:09pm EST)

Naomi Balzer Haas, Hospital of the University of Pennsylvania, USA: Immunotherapy for Prostate and RCC (4:09m EST - 4:21pm EST)

Dave Woodrum, Mayo Clinic, USA: IR for Localized & Advanced Prostate Cancer (4:21pm EST - 4:33pm EST)

Nick Anil Kurup, Mayo Clinic, USA: Addressing Oligometastatic Disease in Prostate and RCC (4:33pm EST - 4:45pm EST)

Abstract Presentation: Preclinical Validation of Synergistic Local Combination of Radiation and PD-L1 Immunotherapy Using Radiation Responsive Nanocarriers for the Treatment of Prostate Cancer, Bongseo Choi (4:45pm EST - 4:52pm EST)

Q&A (4:52pm EST - 5:00pm EST)

Hepatic Dominant Metastatic Disease 

Moderators: John Louie, Stanford University, USA; Franco Orsi, European Institute of Oncology, Italy

John Louie, Stanford University, USA: Liver Dominant Neuroendocrine Disease (3:45pm EST - 3:57pm EST)

Brian Stedman, University Hospital Southampton, UK: Metastatic Melanoma (3:57pm EST - 4:09pm EST)

Franco Orsi, European Institute of Oncology, Italy: Metastatic Breast (4:09m EST - 4:21pm EST)

Damian Dupuy, Brown University, USA: Metastatic Gyn (4:21pm EST - 4:33pm EST)

Eric Hohenwalter, Medical College of Wisconsin, USA: Metastatic Prostate and Kidney (4:33pm EST - 4:45pm EST)

Q&A (4:45pm EST - 5:00pm EST)

Sarcoma

Moderators: Gloria Hwang, Stanford University, USA; Alda Tam, MD Anderson Cancer Center, USA

Brandon Key, Medical College of Wisconsin, USA: Desmoid (5:15pm EST - 5:27pm EST)

Gloria Hwang, Stanford University, USA: Liver Sarcoma Mets (5:27pm EST - 5:39pm EST)

Jean Palussiere, Institut Bergonie, France: Oligometastatic Lung Sarcoma (5:39pm EST - 5:51pm EST)

Peter Littrup, Ascension Crittenton Hospital, USA: Oligometastatic Sarcoma Outside the Lung (5:51pm EST - 6:03pm EST)

Georgia Tsoumakidou, Centre Hospitalier Universitaire Vaudois, Switzerland: Lymph Nodes (6:03pm EST - 6:15pm EST)

Abstract Presentation: Registration Assessment Update of 3D Holographic Models onto a CT Grid Using HoloLens 2 vs HoloLens 1, Ningcheng Li (6:15pm EST - 6:22pm EST)

Q&A (6:22pm EST - 6:30pm EST)

Cases from Two Extremes

Moderators: Muneeb Ahmed, Beth Israel Deaconess Medical Center/ Harvard, USA; Karen Brown, University of Utah, USA

Constantino Peña, Baptist Health South Florida, USA (5:15pm EST - 5:25pm EST)

Bulent Arslan, Rush University, USA (5:25pm EST - 5:35pm EST)

Charles Kim, Duke University, USA (5:35pm EST - 5:45pm EST)

Riad Salem, Northwestern University, USA (5:45pm EST - 5:55pm EST)

Anne Covey, Memorial Sloan Kettering Cancer Center, USA (5:55pm EST - 6:05pm EST)

Yasuaki Arai, National Cancer Center, Japan (6:05pm EST- 6:15pm EST)

Louis Hinshaw, University of Wisconsin, USA (6:15pm EST - 6:25pm EST)

Q&A (6:25pm EST - 6:30pm EST)